Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entry.

Fauvelle C, Lambotin M, Heydmann L, Prakash E, Bhaskaran S, Vishwaraman M, Baumert TF, Moog C.

Hepatol Int. 2017 Sep;11(5):440-445. doi: 10.1007/s12072-017-9809-y. Epub 2017 Jul 11.

PMID:
28698985
2.

Antiviral and Immunoregulatory Effects of Indoleamine-2,3-Dioxygenase in Hepatitis C Virus Infection.

Lepiller Q, Soulier E, Li Q, Lambotin M, Barths J, Fuchs D, Stoll-Keller F, Liang TJ, Barth H.

J Innate Immun. 2015;7(5):530-44. doi: 10.1159/000375161. Epub 2015 Mar 19.

3.

Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept.

Leboeuf C, Roser-Schilder J, Lambotin M, Durand S, Wu T, Fauvelle C, Su B, Bôle-Richard E, Deschamps M, Ferrand C, Tiberghien P, Pessaux P, Baumert TF, Robinet E.

Gene Ther. 2015 Feb;22(2):172-80. doi: 10.1038/gt.2014.99. Epub 2014 Nov 13.

PMID:
25394253
4.

Dendritic cell-lymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cells.

Su B, Biedma ME, Lederle A, Peressin M, Lambotin M, Proust A, Decoville T, Schmidt S, Laumond G, Moog C.

J Virol. 2014 May;88(9):5109-21. doi: 10.1128/JVI.03057-13. Epub 2014 Feb 26.

5.

Efficient transfer of HIV-1 in trans and in cis from Langerhans dendritic cells and macrophages to autologous T lymphocytes.

Peressin M, Proust A, Schmidt S, Su B, Lambotin M, Biedma ME, Laumond G, Decoville T, Holl V, Moog C.

AIDS. 2014 Mar 13;28(5):667-77. doi: 10.1097/QAD.0000000000000193.

PMID:
24451159
6.

Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes.

Su B, Xu K, Lederle A, Peressin M, Biedma ME, Laumond G, Schmidt S, Decoville T, Proust A, Lambotin M, Holl V, Moog C.

Blood. 2012 Nov 1;120(18):3708-17. doi: 10.1182/blood-2012-03-418913. Epub 2012 Sep 6.

PMID:
22955927
7.

Challenges for HCV vaccine development in HIV-HCV coinfection.

Lambotin M, Barth H, Moog C, Habersetzer F, Baumert TF, Stoll-Keller F, Fafi-Kremer S.

Expert Rev Vaccines. 2012 Jul;11(7):791-804. doi: 10.1586/erv.12.52. Review.

PMID:
22913257
8.

Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cells.

Lambotin M, Baumert TF, Barth H.

J Virol. 2010 Sep;84(17):8964-9. doi: 10.1128/JVI.00517-10. Epub 2010 Jun 23.

9.

A look behind closed doors: interaction of persistent viruses with dendritic cells.

Lambotin M, Raghuraman S, Stoll-Keller F, Baumert TF, Barth H.

Nat Rev Microbiol. 2010 May;8(5):350-60. doi: 10.1038/nrmicro2332. Epub 2010 Apr 7. Review.

10.

Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.

Krieger SE, Zeisel MB, Davis C, Thumann C, Harris HJ, Schnober EK, Mee C, Soulier E, Royer C, Lambotin M, Grunert F, Dao Thi VL, Dreux M, Cosset FL, McKeating JA, Schuster C, Baumert TF.

Hepatology. 2010 Apr;51(4):1144-57. doi: 10.1002/hep.23445.

11.

Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells.

Barth H, Schnober EK, Neumann-Haefelin C, Thumann C, Zeisel MB, Diepolder HM, Hu Z, Liang TJ, Blum HE, Thimme R, Lambotin M, Baumert TF.

J Virol. 2008 Apr;82(7):3466-79. doi: 10.1128/JVI.02478-07. Epub 2008 Jan 23.

12.

Invasion of endothelial cells by Neisseria meningitidis requires cortactin recruitment by a phosphoinositide-3-kinase/Rac1 signalling pathway triggered by the lipo-oligosaccharide.

Lambotin M, Hoffmann I, Laran-Chich MP, Nassif X, Couraud PO, Bourdoulous S.

J Cell Sci. 2005 Aug 15;118(Pt 16):3805-16. Epub 2005 Aug 2.

Supplemental Content

Loading ...
Support Center